nitroglycerin has been researched along with spironolactone in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Schröder, R | 1 |
| Wang, W | 1 |
| Imai, F | 1 |
| Makino, H; Nishio, M; Okajima, T; Sugano, S; Suzuki, T | 1 |
| Makino, H; Nishio, M; Sugano, S; Suzuki, T | 1 |
| Bosch, J | 1 |
| Chayama, K; Fujii, Y; Fujimura, N; Hata, T; Hidaka, T; Higashi, Y; Idei, N; Iwamoto, Y; Kato, H; Kihara, Y; Liao, JK; Maruhashi, T; Mikami, S; Noma, K; Soga, J | 1 |
| Goto, M; Hasebe, N; Takahashi, F; Wada, Y | 1 |
3 review(s) available for nitroglycerin and spironolactone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Drug therapy for the treatment of portal hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Combined Modality Therapy; Diuretics; Female; Humans; Hypertension, Portal; Male; Middle Aged; Nitroglycerin; Portal Pressure; Propanolamines; Sclerotherapy; Somatostatin; Spironolactone; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins | 1996 |
The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Transplantation; Lypressin; Middle Aged; Mineralocorticoid Receptor Antagonists; Nadolol; Nitric Oxide Donors; Nitroglycerin; Portasystemic Shunt, Transjugular Intrahepatic; Propranolol; Randomized Controlled Trials as Topic; Recurrence; Sclerotherapy; Spironolactone; Terlipressin; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
2 trial(s) available for nitroglycerin and spironolactone
| Article | Year |
|---|---|
Chronic splanchnic hemodynamic effects of low-dose transdermal nitroglycerin versus low-dose transdermal nitroglycerin plus spironolactone in patients with cirrhosis.
Topics: Administration, Cutaneous; Aged; Dose-Response Relationship, Drug; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Hemodynamics; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Nitroglycerin; Remission Induction; Spironolactone; Splanchnic Circulation; Time Factors; Vasodilator Agents | 1997 |
Mineralocorticoid receptor blocker eplerenone improves endothelial function and inhibits Rho-associated kinase activity in patients with hypertension.
Topics: Angiotensin II Type 1 Receptor Blockers; Calcium Channel Blockers; Cell Movement; Endothelium, Vascular; Eplerenone; Female; Humans; Hypertension; Leukocytes; Losartan; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Nifedipine; Nitroglycerin; rho-Associated Kinases; Spironolactone; Stem Cells; Vascular Endothelial Growth Factor A; Vasodilation | 2012 |
5 other study(ies) available for nitroglycerin and spironolactone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[New aspects of treatment of hemodynamic complications in acute myocardial infarction (author's transl)].
Topics: Animals; Canrenoic Acid; Digitalis Glycosides; Dogs; Dopamine; Furosemide; Hemodynamics; Humans; Myocardial Infarction; Nitroglycerin; Phentolamine; Shock, Cardiogenic; Spironolactone | 1977 |
Chronic administration of aldosterone depresses baroreceptor reflex function in the dog.
Topics: Aldosterone; Animals; Baroreflex; Blood Pressure; Catheters, Indwelling; Dogs; Female; Heart Rate; Infusions, Parenteral; Male; Nitroglycerin; Ouabain; Phenylephrine; Pressoreceptors; Reference Values; Regression Analysis; Spironolactone; Time Factors | 1994 |
Relationship of portal pressure and colorectal vasculopathy in patients with cirrhosis.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Colon; Female; Humans; Intestinal Mucosa; Liver Cirrhosis; Male; Middle Aged; Nitroglycerin; Portal Pressure; Rectum; Spironolactone; Varicose Veins; Vasodilator Agents | 1999 |
Successful Treatment with an Antihypertensive Drug Regimen Including Eplerenone in a Patient with Malignant Phase Hypertension with Renal Failure.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Creatinine; Drug Therapy, Combination; Eplerenone; Heart Failure; Humans; Hypertension, Malignant; Male; Nifedipine; Nitroglycerin; Obesity; Renal Insufficiency; Spironolactone; Tetrazoles; Treatment Outcome; Vasodilator Agents | 2015 |